Edwards Lifesciences, Benitec Biopharma, Stemline Therapeutics Stocks Moving Today

EW, BNTC, STML are among the stocks on the move today

Feb 2, 2017 at 2:53 PM
facebook X logo linkedin

U.S. stocks are trading lower, with growing political tensions setting a risk-off mood. Among specific equities in focus today are healthcare stocks Edwards Lifesciences Corp (NYSE:EW), Benitec Biopharma Ltd (ADR) (NASDAQ:BNTC), and Stemline Therapeutics Inc (NASDAQ:STML). Here's a quick look at what's moving EW, BNTC, and STML.

Bearish Analysts Sink Edwards Lifesciences Corp

Even though the company reported fourth-quarter earnings results that topped expectations, shares of EW were last seen 9.4% lower at $88.83. The stock this morning received price-target cuts from Deutsche Bank ($100) and Leerink ($105), with the latter brokerage suggesting upside will be limited from current levels. Edwards Lifesciences Corp has now shed 27% since its October record high of $121.75. If the shares do struggle going forward, more bearish attention could come EW's way, since 16 of 18 analysts rate it a "buy" or "strong buy," while zero recommend selling the stock. 

Benitec Biopharma Ltd Doubles in Value After Ocular Program Update

BNTC was last seen sporting a 125% gain at $3.60 -- making it the top stock on the Nasdaq -- after the company said it's made "significant progress" with its ocular program. Details will be presented at the Association for Research in Vision and Ophthalmology (ARVO)-Asia meeting in the coming days. This is the stock's second huge upside move this month, and the shares earlier tagged an annual high of $4.44. At last check, volume on Benitec Biopharma Ltd was running at seven times the norm

Reports of Patient Death Crush Stemline Therapeutics Inc

STML is down 35.1% at $6.33, after The Street.com reported a third patient has died in a clinical trial for the company's leukemia treatment. The stock is now on pace for its lowest close since May, and bearish traders couldn't be happier. For instance, short interest on Stemline Therapeutics Inc rose by 25.5% during the past two reporting periods, and now represents more than a week's worth of buying power, based on the stock's average daily volumes. 

Get a jump-start on the day's stock market news with Schaeffer's free Opening View newsletter.

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI